Who owns Nektar Therapeutics?
- CUSIP Number: 640268108
Tip: Access positions for across all investors
Analyze quarterly positions in Nektar Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Nektar Therapeutics stock
Who bought or sold Nektar Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| 49 Wealth Management | 5.4k | $230k | -9% | Dec 2025 |
|
| Parallel Advisors | 1.1k | $60k | 0% | Sep 2025 |
|
| Farther Finance Advisors | 141.00 | $6.0k | 100% | Dec 2025 |
|
| EverSource Wealth Advisors | 110.00 | $4.7k | 0% | Dec 2025 |
|
| Rise Advisors | 69.00 | $3.9k | 41% | Sep 2025 |
|
| Nova Wealth Management | 40.00 | $1.7k | 150% | Dec 2025 |
|
| Fortitude Family Office | 21.00 | $887.999700 | 0% | Dec 2025 |
|
| AllSquare Wealth Management | 18.00 | $1.0k | 0% | Sep 2025 |
|
| Huntington National Bank | 1.00 | $1.000000 | 0% | Dec 2025 |
|
| LRI Investments | 1.00 | $42.000000 | 0% | Dec 2025 |
|